左旋甲状腺素对亚临床甲状腺功能减退及临床甲状腺功能减退的疗效分析
2018-03-31钟一禾
钟一禾
[摘要] 目的 探讨左旋甲状腺素治疗亚临床甲状腺功能减退及临床甲状腺功能减退的临床疗效。方法 方便选取2016年11月—2017年8月该院86例亚临床甲状腺功能减退、临床甲状腺功能减退患者为例,分为实验组(左旋甲状腺素钠片,43例)和对照组(甲状腺片,43例)。对比观察两组甲状腺功能血生化指标。结果 实验组临床甲减患者治疗后FT3(3.75±0.64)pmol/mL,FT4(9.46±1.97)pmol/mL,亚临床甲减患者TSH(7.40±1.13)mU/L,各项指标与对照组比较差异有统计学意义(P<0.05)。结论 左旋甲状腺激素治疗亚临床甲状腺功能减退及临床甲状腺功能减退的疗效优于甲状腺片,值得临床推广使用。
[关键词] 亚临床甲状腺功能减退;临床甲状腺功能减退;左旋甲状腺素
[中图分类号] R581 [文献标识码] A [文章编号] 1674-0742(2018)01(a)-0154-03
Efficacy of L-thyroxine on Subclinical Hypothyroidism and Clinical Hypothyroidism
ZHONG Yi-he
Endocrinology Department, Liyang Traditional Chinese Medicine Hospital, Liyang, Jiangsu Province, 213300 China
[Abstract] Objective This paper tries to investigate the clinical effect of L-thyroxine on subclinical hypothyroidism and clinical hypothyroidism. Methods 86 cases of subclinical hypothyroidism, clinical hypothyroidism patients from November 2016 to August 2017 in this hospital were conveniently selected and divided into experimental group (levothyroxine sodium tablets, 43 cases) and control group (thyroid tablets, 43 cases). The blood biochemical parameters of thyroid function in two groups were observed and compared. Results The experimental group patients with clinical hypothyroidism after treatment of FT3 (3.75±0.64) pmol/mL, FT4 (9.46±1.97) pmol/mL, TSH patients with subclinical hypothyroidism (7.40±1.13) mU/L, there were significant differences between the indexes of the two groups(P<0.05). Conclusion Levothyroxine therapy is superior to thyroid tablets in the treatment of subclinical hypothyroidism and hypothyroidism, and is worthy of clinical use.
[Key words] Subclinical hypothyroidism; Clinical hypothyroidism; Levothyroxine
臨床甲状腺功能减退(简称临床甲减)是甲状腺激素合成不足、分泌减少或生理效应下降所引起的代谢性疾病,可引起神经、心血管、消化道、内分泌等多组织器官症状[1]。其中,仅促甲状腺激素(TSH)升高,其他指标正常的甲减称亚临床甲状腺功能减退(简称亚临床甲减),此类患者通常无症状,仅部分可见皮肤干燥、记忆力差、反应迟钝、肌无力等,如不经治疗,约20%~50%的患者可进展为临床甲减,或可能出现血脂升高、神经心理症状及不良心脏终点事件等[2]。口服甲状腺激素是临床治疗亚临床甲减和临床甲减的有效方法,文章现以2016年11月—2017年8月该院86例患者为例,对左旋甲状腺素的治疗效果进行分析和探讨,现报道如下。
1 资料与方法
1.1 一般资料
方便选取该院86例亚临床甲减、临床甲减患者为例,依据治疗方法分为两组。实验组(43例):男8例,女35例;年龄23~68岁,平均(45.2±11.3)岁;亚临床甲减18例,临床甲减25例。……
